US 2023/0381250 A1Published application

Composition for prevention or treatment of alzheimer's disease comprising lactobacillus sakei probio-65

AssigneeProbionic Corp.

InventorsYong-Ha Park, Min-Tze Liong

Life of this patent

Estimating the term…

Abstract

The present invention relates to a composition for prevention or treatment of Alzheimer's disease comprising Lactobacillus sakei Probio-65, and more particularly, it relates to a composition for the prevention or treatment of Alzheimer's disease containing Lactobacillus sakei Probio-65 which may alleviate Alzheimer's disease through changes in the profile of intestinal microorganisms and intestinal metabolome composition without side effects.

Claims7

Dependent claims

A composition for prevention or treatment of Alzheimer's disease comprising:

Lactobacillus sakei Probio-65 as an active ingredient.

Dependencies are inferred from the claim text.

Facts

Application: 18/027,351Filed 22 Oct 2020
Priority: KR 10-2020-012271623 Sep 2020
Published: 30 Nov 2023
Term ends: Not estimatedThe source records don’t support an estimate.

Classification18 codes

A61K 35/747
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs: lactobacilli, e.g. L. acidophilus or L. brevis
A23K 10/18
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions: of live microorganisms
A23L 33/135
Using additives: bacteria or derivatives thereof, e.g. probiotics
A61K 8/99
Containing materials, or derivatives thereof of undetermined constitution: from microorganisms other than algae or fungi, e.g. protozoa or bacteria

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results